4

4

SEC Filing Details

Document Details

Form
Filing Date
Jun 3, 2021
Document Date
06/02/21
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Protalix BioTherapeutics
Issuer
Protalix BioTherapeutics, Inc.
Filer
Dexcel Pharma Technologies Ltd.